Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension (2005)
- Authors:
- USP affiliated author: SOUZA, ROGÉRIO DE - FM
- School: FM
- DOI: 10.1185/030079905x46232
- Subjects: HIPERTENSÃO PULMONAR (TERAPIA); HIPERTENSÃO PULMONAR (EFEITOS DE DROGAS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Current Medical Research and Opinions
- ISSN: 0300-7995
- Volume/Número/Paginação/Ano: v. 21, n. 6, p. 907-911, 2005
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUZA, Rogerio de; JARDIM, Carlos; MARTINS, Bárbara; et al. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions, London, v. 21, n. 6, p. 907-911, 2005. DOI: 10.1185/030079905x46232. -
APA
Souza, R. de, Jardim, C., Martins, B., Cortopassi, F., Yaksic, M., Rabelo, R., & Bogossian, H. (2005). Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions, 21( 6), 907-911. doi:10.1185/030079905x46232 -
NLM
Souza R de, Jardim C, Martins B, Cortopassi F, Yaksic M, Rabelo R, Bogossian H. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions. 2005 ; 21( 6): 907-911. -
Vancouver
Souza R de, Jardim C, Martins B, Cortopassi F, Yaksic M, Rabelo R, Bogossian H. Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension. Current Medical Research and Opinions. 2005 ; 21( 6): 907-911. - TEP com instabilidade hemodinâmica
- Atualização em hipertensão arterial pulmonar
- RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study
- Reperfusion in acute pulmonary thromboembolism
- Unusual cause of wheezing [Editorial]: extrinsic bronchial compression by pulmonary artery aneurysm
- Building the Future of Trial Design in PAH on Solid Ground
- Pulmonary arterialhHypertension-related morbidity is prognostic for mortality
- Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial
- Pulmonary hypertension in sickle cell disease
- Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension [Editorial]
Informações sobre o DOI: 10.1185/030079905x46232 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
